Clinical Trials Browser

INDUSTRY × Axitinib × Gastrointestinal × Clear all

NCT04458259 2025-08-28

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Phase 1 Terminated

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT00219557 2019-05-14

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

Phase 2 Completed

111 enrolled 20 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01210495 2019-01-09

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Phase 2 Completed

224 enrolled 35 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00460603 2013-12-06

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

Phase 1/2 Completed

187 enrolled 47 charts

Gastrointestinal

Colorectal Neoplasms

NCT00842244 2013-11-27

Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer

Phase 1 Completed

22 enrolled 20 charts

Gastrointestinal

Stomach Neoplasms

NCT00615056 2013-04-19

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

Phase 2 Completed

171 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT00471146 2012-07-16

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Phase 3 Completed

630 enrolled 13 charts

Gastrointestinal

Carcinoma, Pancreatic Ductal

NCT01441388 2011-12-20

A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Phase 1 Withdrawn

CNSGastrointestinalGenitourinary

Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular